New obesity drug BMF-650 enters early human safety testing
NCT ID NCT07223216
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times
Summary
This early-stage study tests a new drug called BMF-650 in 80 healthy adults who are overweight or obese. The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo, and researchers monitor side effects and vital signs. This is not a cure for obesity but aims to help manage weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Medpace Clinical Pharmacology
Cincinnati, Ohio, 45227, United States
Conditions
Explore the condition pages connected to this study.